RxDoctor Payments Data

Salah El Hafi

Interventional Cardiology · Houston, TXNPI 1396969622

Payments from drug & device makers

$9,474in general payments, 2019–2025

Across 110 payments — averaging $86.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • AstraZeneca$3K
  • Novartis$1K
  • Astellas Pharma US Inc$268
  • Johnson & Johnson$185
  • Amgen$167
  • plus $731 from 12 others

What the payments were for

  • Travel & lodging$2,65352%
  • Food & beverage$2,25244%
  • Education$1954%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,474 in reported general payments places this provider in the 45th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Other interventional cardiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →